Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension in the elderly

W C Cushman1

  • 1University of Tennessee College of Medicine, Memphis.

Current Opinion in Cardiology
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Treating hypertension in the elderly is crucial for reducing cardiovascular events. Studies show significant benefits from blood pressure management, particularly for systolic hypertension.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health Implications of the MTM Eligibility Criteria In The Affordable Care Act Across Racial And Ethnic Groups.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Importance of potassium in cardiovascular disease.

Journal of clinical hypertension (Greenwich, Conn.)·2002
Same author

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience.

Controlled clinical trials·2001
Same author

Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial.

Hypertension (Dallas, Tex. : 1979)·2001
Same author

Systolic hypertension and cardiovascular risk reduction: a clinical review.

Current hypertension reports·2001
Same author

Clinical overview of hypertension and emerging treatment considerations.

American journal of hypertension·2001
Same journal

An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026
Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026
Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026
Same journal

Advances in artificial intelligence for the evaluation of mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Role of nutritional interventions to reduce cardiometabolic disease burden in the community.

Current opinion in cardiology·2026
See all related articles

Area of Science:

  • Gerontology
  • Cardiology
  • Public Health

Background:

  • Hypertension is a primary risk factor for cardiovascular events in older adults, affecting over 50% of Americans over 60.
  • Both systolic and diastolic blood pressure increase cardiovascular risk, with systolic pressure being particularly critical in the elderly.
  • Isolated systolic hypertension in the elderly predicts future hypertension and elevates cardiovascular event risk.

Purpose of the Study:

  • To review the evidence supporting hypertension treatment in the elderly.
  • To examine the effectiveness of different antihypertensive drug classes in older populations.
  • To highlight the benefits demonstrated by morbidity trials, such as the Systolic Hypertension in the Elderly Program.

Main Methods:

  • Analysis of morbidity trials focusing on hypertension in the elderly population.

Related Experiment Videos

  • Review of treatment outcomes across different demographic subgroups (e.g., race).
  • Examination of physician prescribing patterns for antihypertensive medications.

    • Main Results:

    • Morbidity trials, including the Systolic Hypertension in the Elderly Program, confirm significant benefits of hypertension treatment in all elderly subgroups.
    • Diuretics and beta-blockers showed benefits, though physician initiation of these therapies was suboptimal in 1990-1991.
    • All major drug classes effectively lower blood pressure in older white patients; calcium antagonists and diuretics are most effective in older black patients.

    Conclusions:

    • Hypertension management is vital for reducing cardiovascular morbidity and mortality in the elderly.
    • Evidence supports the efficacy of various antihypertensive agents, with specific recommendations based on race.
    • Further efforts are needed to ensure optimal pharmacotherapy initiation and adherence in elderly hypertensive patients.